Bank of America restated their buy rating on shares of Change Healthcare (NASDAQ:CHNG) in a research report report published on Monday morning, TipRanks reports. They currently have a $15.00 target price on the stock.
Several other brokerages also recently weighed in on CHNG. Goldman Sachs Group reaffirmed a buy rating on shares of Change Healthcare in a research report on Wednesday, March 18th. Barclays dropped their target price on Change Healthcare from $18.00 to $14.00 and set an overweight rating on the stock in a report on Thursday, April 9th. SVB Leerink assumed coverage on Change Healthcare in a research report on Monday, April 13th. They set an outperform rating and a $13.00 price target for the company. Raymond James raised Change Healthcare from an outperform rating to a strong-buy rating and set a $20.00 price target for the company in a report on Wednesday, March 18th. Finally, Credit Suisse Group reaffirmed a buy rating and set a $16.00 price objective on shares of Change Healthcare in a research note on Wednesday, May 6th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Change Healthcare has a consensus rating of Buy and an average target price of $17.03.
Shares of NASDAQ:CHNG opened at $10.47 on Monday. Change Healthcare has a twelve month low of $6.18 and a twelve month high of $17.57. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 1.43. The company has a market cap of $3.33 billion and a PE ratio of 261.82. The company’s 50 day moving average is $11.77 and its 200 day moving average is $12.80.
In other Change Healthcare news, CFO Fredrik J. Eliasson bought 100,000 shares of the stock in a transaction on Wednesday, June 10th. The shares were bought at an average price of $12.00 per share, with a total value of $1,200,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Hedge funds have recently bought and sold shares of the company. Great West Life Assurance Co. Can acquired a new stake in shares of Change Healthcare in the fourth quarter valued at approximately $54,000. UBS Group AG purchased a new stake in Change Healthcare in the 4th quarter valued at $61,000. Citigroup Inc. increased its stake in shares of Change Healthcare by 66.3% in the 4th quarter. Citigroup Inc. now owns 5,701 shares of the company’s stock worth $93,000 after acquiring an additional 2,272 shares during the last quarter. Alambic Investment Management L.P. purchased a new position in shares of Change Healthcare during the 4th quarter worth $170,000. Finally, Amalgamated Bank boosted its position in shares of Change Healthcare by 9.8% during the 4th quarter. Amalgamated Bank now owns 11,993 shares of the company’s stock valued at $197,000 after acquiring an additional 1,068 shares during the last quarter.
Change Healthcare Company Profile
Change Healthcare Inc, an independent healthcare technology platform, provides data and analytics-driven solutions to improve clinical, financial, and patient engagement outcomes in the United States healthcare system. It operates in three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services.
Further Reading: Understanding Options Trading
Receive News & Ratings for Change Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Change Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.